You draw very long bows....... too long.
Schinazi is much more famous for his part in the discovery and trialling of Sofosbuvir for HCV.
Biotron used Gilead's drug because it is a single combination, approved in Thailand, and it is well and truly the best HIV ART drug combo.
Gilead sponsor nearly every big conference. They spend more on advertising than they do on research.
Gilead are trialling their own drugs against HIV, and are in the middle of large human trial. If successful, they won't require anyone else's drug. So far, they have already cured SIV in macaques. They are well ahead of the field, as usual.
- Forums
- ASX - By Stock
- Big buy
You draw very long bows....... too long. Schinazi is much more...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $4.225K | 222.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1639605 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 80000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1639605 | 0.019 |
11 | 2301165 | 0.018 |
5 | 688000 | 0.017 |
11 | 1524225 | 0.016 |
4 | 660000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 80000 | 1 |
0.021 | 188000 | 3 |
0.022 | 600000 | 2 |
0.023 | 307000 | 2 |
0.024 | 255035 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online